1 min read News Hub Glenmark Pharma rises 4% after Favipiravir shows encouraging results in Phase 3 trial 6 months ago Debarati Mondal
2 min read News Hub Glenmark’s Fabiflu is first in the market, but growth opportunity limited 7 months ago Debarati Mondal